Patterson Elissa H, Miller Chazlyn, Hannapel Madison
Institute for Healthcare Policy & Innovation, Consultation Liaison Psychiatry, Departments of Psychiatry and Neurology, University of Michigan Medical School, Ann Arbor, MI, United States.
Effects of Discrimination and Privilege Laboratory, Department of Psychology, Eastern Michigan University, Ypsilanti, MI, United States.
Front Psychiatry. 2025 Jun 3;16:1600094. doi: 10.3389/fpsyt.2025.1600094. eCollection 2025.
It has been known since ancient times that the mind, body, and social connection are intertwined to promote thriving. More specifically, the basic pillars of health and wellbeing have been described across cultures, and they are codified in modern healthcare as the principles of lifestyle medicine. However, across the globe, emotional despair, loneliness, and chronic diseases have been rising despite a wealth of knowledge about the elements that promote happy, healthy individuals and communities. Depression has been identified as a significant element of the global mental health crisis. We know that depression is a multifaceted condition influenced by biological, psychological, social, environmental, and spiritual factors, but prevailing medical models prioritize medication and overshadow the importance of the other facets. In healthcare, pharmaceutical companies comprise a major portion of innovation that has led to the development of invaluable life-saving medications. However, some psychiatric drug makers use marketing methods rather than the scientific method to test and promote the sale of drugs to treat depression. For example, a confidential data ownership and transfer agreement that came to light during litigation over an antidepressant drug, stated that the purpose of the data collected by the drug company sponsored research was to market their product. The public and the medical community have been led to believe that drugs are more scientifically valid than other approaches to depression. We suggest a more holistic approach to prevention and treatment of emotional despair and depression, an approach that uses a public psychology lens to promote societal wellbeing.
自古以来就知道,心理、身体和社会联系相互交织以促进繁荣。更具体地说,健康和幸福的基本支柱在不同文化中都有描述,并且在现代医疗保健中被编纂为生活方式医学的原则。然而,尽管有大量关于促进个人和社区幸福、健康的要素的知识,但全球范围内的情绪绝望、孤独和慢性病却一直在增加。抑郁症已被确定为全球心理健康危机的一个重要因素。我们知道抑郁症是一种受生物、心理、社会、环境和精神因素影响的多方面状况,但主流医学模式将药物治疗置于优先地位,而忽视了其他方面的重要性。在医疗保健领域,制药公司是创新的主要组成部分,这些创新带来了极其宝贵的救命药物的开发。然而,一些精神科药物制造商使用营销手段而非科学方法来测试和推广治疗抑郁症药物的销售。例如,在一场关于一种抗抑郁药物的诉讼中曝光的一份机密数据所有权和转移协议表明,由制药公司赞助的研究所收集数据的目的是推销其产品。公众和医学界一直被引导去相信药物比治疗抑郁症的其他方法在科学上更有效。我们建议采用一种更全面的方法来预防和治疗情绪绝望和抑郁症,这种方法使用公共心理学视角来促进社会福祉。